Theorem Clinical Research recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud.
Theorem Clinical Research, a contract research organization that optimizes trial conduct, recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud.
This accreditation enables Theorem to provide a unified approach to capture data directly from patients. Clinical investigators and sponsors will gain operational efficiencies with immediate access to review electronic patient reported outcomes (ePRO) data in one platform while leveraging Theorem’s clinical expertise.
“We will be able to transform what can be a lengthy and expensive process into a fast implementation using Medidata’s platform of cloud-based solutions, which includes capabilities to facilitate direct communication with patients,” said Mark Penniston, executive vice president and general manager for clinical analytics.
“Theorem shares our vision of bringing the voice of the patient into clinical research and positively transforming the clinical trial experience for all study participants,” said Steve Heath, Medidata’s vice president of channel sales. “This accreditation reinforces Theorem’s commitment to leveraging innovative technology to accelerate the delivery of medicine to patients around the world.”
Theorem has built hundreds of studies in Medidata Rave and is a top holder of accreditations among Medidata Services Partners with accreditation in:
Theorem clinical analytics experts will deliver two presentations during the
Medidata Symposium 2014
April 23–25 in San Francisco:
Additionally, innovative solutions will be featured during the symposium in the Innovation Lounge, including automation of mapping from Medidata Rave into CDISC-compliant data sets via SAS CDI and real-time data visualizations from Medidata Rave to Spotfire visual analytics.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.